Implications of Calcineurin/NFAT Inhibitors' Regulation of Dendritic Cells and Innate Immune Cells in Islet Xenotransplantation.
- Author:
Yong Hee KIM
1
;
Won Woo LEE
;
Chung Gyu PARK
Author Information
- Publication Type:Review
- Keywords: Calcineurin inhibitors; Innate immunity; Islet transplantation; Xenotransplantation
- MeSH: Calcineurin; Critical Pathways; Cyclooxygenase 2; Cyclosporine; Dendritic Cells*; Immunity, Innate; Interleukin-2; Islets of Langerhans Transplantation; Macrophages; Organ Transplantation; T-Lymphocytes; Tacrolimus; Transcription Factors; Transplantation; Transplantation, Heterologous*; Transplants
- From:Journal of Bacteriology and Virology 2016;46(1):1-12
- CountryRepublic of Korea
- Language:English
- Abstract: Calcineurin inhibitors, such as cyclosporine and tacrolimus (FK506) are broadly used in organ transplantations as immune suppressants. As the calcineurin/NFAT signaling pathway has been identified as critical pathway in the interleukin-2 (IL-2) production of T cells, inhibition of T-cell derived IL-2 has been considered the major mechanism of calcineurin inhibitors. However, there is increasing evidence that NFAT transcription factor is involved in multiple functions of dendritic cells and innate immune cells as well. NFAT expression is not restricted to T cells, and IL-2 can be produced in dendritic cells and macrophages through the calcineurin/NFAT pathway. Furthermore, it has been discovered that NFAT regulates expressions of several inflammatory mediators, including TNF-α and cyclooxygenase-2 in innate immune cells. Therefore, calcineurin inhibitors may have much broader effects in the transplant recipients than previously being considered. In this review, we reviewed recently discovered roles of NFAT pathway in dendritic cells and innate immune cells, and discussed positive and negative implications of calcineurin inhibitors' broader effects with a focus on islet xenotransplantation.
